Technology
Health
Biopharmaceutical

CTI BioPharma

$1.04
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.95%) As of 3:59 PM EDT today

Why Robinhood?

You can buy or sell CTI BioPharma and other stocks, options, ETFs, and crypto commission-free!

About CTIC

CTI BioPharma Corp. (DE) Common Stock, also called CTI BioPharma, is a biopharmaceutical company, which focuses on the development, acquisition and commercialization of novel targeted therapies for blood-related cancers. Read More It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. The listed name for CTIC is CTI BioPharma Corp. (DE) Common Stock.

CEO
Adam R. Craig
Employees
25
Headquarters
Seattle, Washington
Founded
1991
Market Cap
75.93M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
5.91K
High Today
$1.06
Low Today
$1.02
Open Price
$1.04
Volume
82.63K
52 Week High
$1.95
52 Week Low
$0.6487

Collections

Technology
Health
Biopharmaceutical
Pharmaceutical
2014 IPO
US
North America

CTIC Earnings

-$0.58
-$0.38
-$0.19
$0.01
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 5, After Hours

You May Also Like

IEFA
LDRS
HTBK
AMK
XLRN
PSCI
CWH
GXF
QRTEP
LMRK
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.
Buy CTIC
Market Price
$1.04
Commissions
$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell CTI BioPharma stock and options commission-free.
LearnBlogCareersHelpLog InSign Up